Jump to Content Jump to Main Navigation

HSR21-073: Febrile Neutropenia Outcomes Among Patients With Breast Cancer and Non-Hodgkin’s Lymphoma Receiving Pegfilgrastim Prophylaxis: A Real-World Analysis of Commercial and Medicare Claims From 2017-2018

Authors: Weijia Wang MSc, Edward Li PharmD, MPH¹, Kim Campbell PharmD, BCOP¹, and Ali McBride PharmD, MS, BCOP, FAzPA, FASHP^2,3

View More View Less

¹ Sandoz Inc., Princeton, NJ
| ² Banner University Medical Center, Tucson, AZ
| ³ University of Arizona Cancer Center, Tucson, AZ

Volume/Issue:: Volume 19: Issue 3.5

Online Publication Date:: 17 Mar 2021

DOI:: https://doi.org/10.6004/jnccn.2020.7718

Restricted access

All currencies in US Dollar

Corresponding Author: Weijia Wang, MSc

Print
Save
Cite
Email this content

Share Link

Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:

https://jnccn.org/abstract/journals/jnccn/19/3.5/article-pHSR21-073.xml
The link was not copied. Your current browser may not support copying via this button.

Link copied successfully

Top

Copyright:: Copyright © 2021 by the National Comprehensive Cancer Network 2021

Article Category:: Abstract

Print Publication Date:: 20 Mar 2021

Online Publication Date:: 17 Mar 2021

Get Permissions

Similar articles in Google Scholar

	All Time	Past Year	Past 30 Days
Abstract Views	0	0	0
Full Text Views	185	185	8
PDF Downloads	213	213	5
EPUB Downloads	0	0	0